Obviously Nine Believers: Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.

Clicks: 336
ID: 59213
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #1 of 2 articles by views in basic & clinical pharmacology & toxicology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
A recent publication in Clinical Pharmacology and Therapeutics (CPT) by van der Wouden and colleagues on the preemptive pharmacogenomic PGx Passport, intended to optimize drug prescribing, caught my attention. I believe that the overall narrative of the paper is disproportional to the supporting evidence. The Editors of CPT did not find that my comment and reflections on this paper could be prioritized. I hope that BCPT will endorse a discussion of how we, as a research community, frame and disseminate our findings.
Reference Key
damkier2019obviouslybasic Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Damkier, Per;
Journal basic & clinical pharmacology & toxicology
Year 2019
DOI
10.1111/bcpt.13335
URL
Keywords
precision medicine clinical pharmacogenomics dissemination of research pharmacogenetics/pharmacogenomics rational pharmacotherapy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.